[1]
Tyagi, R.; Verma, S.; Mishra, S.; Srivastava, M.; Alam, S.; Khan, F.; Srivastava, S.K. In Vitro and in silico studies of glycyrrhetinic acid derivatives as anti-filarial agents. Curr. Top. Med. Chem., 2019, 19(14), 1191-1200.
[2]
Vil’, V.A.; Terent’ev, A.O.; Mulina, O.M. bioactive natural and synthetic peroxides for the treatment of helminth and protozoan pathogens: Synthesis and properties. Curr. Top. Med. Chem., 2019, 19(14), 1201-1225.
[3]
Murthy, P.K. Strategies to control human lymphatic filarial infection: Tweaking host’s immune system. Curr. Top. Med. Chem., 2019, 19(14), 1226-1240.
[4]
Rando, D.G.G.; da Costa, M.O.L.; Pavani, T.F.A.; Oliveira, T.; dos Santos, P.F.; Amorim, C.R.; Pinto, P.L.S.; de Brito, M.G.; Silva, M.P.N.; Roquini, D.B.; de Moraes, J. Vanillin-related N-acylhydrazones: Synthesis, antischistosomal properties and target fishing studies. Curr. Top. Med. Chem., 2019, 19(14), 1241-1251.
Current Topics in Medicinal Chemistry
Title:Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis
Volume: 19 Issue: 14
Author(s): Santosh K. Srivastava
Affiliation:
Export Options
About this article
Cite this article as:
Srivastava K. Santosh , Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis, Current Topics in Medicinal Chemistry 2019; 19 (14) . https://dx.doi.org/10.2174/156802661914190828124745
DOI https://dx.doi.org/10.2174/156802661914190828124745 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
22
3
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances in Obesity Pharmacotherapy
Current Clinical Pharmacology Editorial [Hot Topic: Drug Discovery for CNS Disorders: From Bench to Bedside (Guest Editor: Tiago Fleming Outeiro)]
CNS & Neurological Disorders - Drug Targets The Role of Matrix Metalloproteinase Inhibitors in Ischemia-Reperfusion Injury in the Liver
Current Pharmaceutical Design Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid
Current Alzheimer Research Towards the Molecular Foundations of Glutamatergic-targeted Antidepressants
Current Neuropharmacology Glutamatergic Neurotransmission As Molecular Target of New Anticonvulsants
Current Topics in Medicinal Chemistry Improved Prediction of Protein Ligand-Binding Sites Using Random Forests
Protein & Peptide Letters Therapeutic Challenges in Neuroendocrine Tumors
Anti-Cancer Agents in Medicinal Chemistry Induction of Tumour Cell Senescence: A New Strategy in Anticancer Treatment
Medicinal Chemistry Reviews - Online (Discontinued) Tau as a Therapeutic Target for Alzheimers Disease
Current Alzheimer Research Glucocorticoids, the Etiology of Obesity and the Metabolic Syndrome
Current Alzheimer Research Hangover and Risk for Alcohol Use Disorders: Existing Evidence and Potential Mechanisms
Current Drug Abuse Reviews Functional Activity and Connectivity Differences of Five Resting-State Networks in Patients with Alzheimer’s Disease or Mild Cognitive Impairment
Current Alzheimer Research Oxidative Stress in the Pathogenesis of Alzheimer’s Disease and Cerebrovascular Disease with Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Designed Multiple Ligands: Basic Research vs Clinical Outcomes
Current Medicinal Chemistry Cognitive Abilities of Alzheimers Disease Transgenic Mice are Modulated by Social Context and Circadian Rhythm
Current Alzheimer Research Novel Nucleic Acid-Based Agents: siRNAs and miRNAs
Central Nervous System Agents in Medicinal Chemistry Cardiovascular Biology of Interleukin-6
Current Pharmaceutical Design The Role of Melatonin in the Immuno-Neuro-Psychology of Mental Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Design, Synthesis and Evaluation of Novel 2-piperidinyl Quinoline Chalcones/ Amines as Potential Antidepressant Agents
Letters in Drug Design & Discovery